Multicenter Study on Observation of Acute-phase Responses After Infusion of Zoledronic Acid 5 mg in Chinese Women with Postmenopausal Osteoporosis.

about

Multicenter Study on Observation of Acute-phase Responses After Infusion of Zoledronic Acid 5 mg in Chinese Women with Postmenopausal Osteoporosis.

Item

http://www.wikidata.org/entity/Q41928631

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Multicenter Study on Observati ...... h Postmenopausal Osteoporosis.

@en

type

Item

label

Multicenter Study on Observati ...... h Postmenopausal Osteoporosis.

@en

prefLabel

Multicenter Study on Observati ...... h Postmenopausal Osteoporosis.

@en

P1476

Multicenter Study on Observati ...... th Postmenopausal Osteoporosis

@en

P2093

Chao Zhang

http://www.w3.org/2001/XMLSchema#string

Chun-Lin Zhang

http://www.w3.org/2001/XMLSchema#string

Fu-Xing Pei

http://www.w3.org/2001/XMLSchema#string

Hua Lin

http://www.w3.org/2001/XMLSchema#string

Jian-Cheng Zeng

http://www.w3.org/2001/XMLSchema#string

Qing-Yun Xue

http://www.w3.org/2001/XMLSchema#string

Shi-Xun Li

http://www.w3.org/2001/XMLSchema#string

Xun Liu

http://www.w3.org/2001/XMLSchema#string

Yan Zhang

http://www.w3.org/2001/XMLSchema#string

Yue Ding

http://www.w3.org/2001/XMLSchema#string

P2860

The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins

Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research

Bisphosphonates and bone quality.

Intravenous zoledronic acid in postmenopausal women with low bone mineral density.

Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010

Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study)

Benefits and risks of bisphosphonate therapy for osteoporosis.

Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons.

Short-term and long-term effects of osteoporosis therapies.

Zoledronic acid inhibits macrophage SOCS3 expression and enhances cytokine production

P304

284-289

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/OS.12338

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fei Yin

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28960821

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis

multicenter trial

P932

6584091

http://www.w3.org/2001/XMLSchema#string